Spanish 
English 
November 11, 2025
Influenza | RSV | COVID: Active Vaccination/Immunity
November 7, 2025
SARS-CoV-2 | HPV Vaccination | Bird Flu | COVID: Active Vaccination/Immunity | COVID: Early Viral Stage | COVID: The Late Phase/PASC/Long COVID
The Impact of This Week in Parasitism on the Public Understanding of Science
Found under the ‘Resources’ tab of our website, the course was developed by Parasites Without Borders in conjunction with a team of fellows and medical educators at Columbia University Irving Medical Center and was revised by a panel of expert clinicians and researchers from all around the world.
The Impact of This Week in Parasitism on the Public Understanding of Science Read More »
October 30, 2025
SARS-CoV-2 mRNA Vaccination: Cancer Benefit | Viral Infection and Cardiovascular Disease | RSV: Revaccination | COVID: Active Vaccination/Immunity
October 23, 2025
Measles Without Rash During Acute Febrile Illness Surveillance in Tanzania, 2023-2024 | Susceptibility of Measles Virus to WHO Hand Rubs, Oral and Surface Disinfectants | Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season
October 15, 2025
Effectiveness of NVX-CoV2373 and BNT162b2 COVID-19 Vaccination in South Korean Adolescents | Antiviral Efficacy of Oral Ensitrelvir versus Oral Ritonavir-boosted Nirmatrelvir in COVID-19 (PLATCOV): An Open-label, Phase 2, Randomised, Controlled, Adaptive Trial | Longitudinal Patient-reported Outcome Trajectories in Long COVID: Findings from the STOP-PASC Clinical Trial
October 11, 2025
Comparison of 2 Doses vs 1 Dose in the First Season Children Are Vaccinated Against Influenza: A Systematic Review and Meta-Analysis | Neonatal Outcomes Among Pregnant Women with COVID-19: A Systematic Scoping Review and Meta-analysis | Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
October 2, 2025
Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season | Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort | FDA Conditionally Approves First Drug for Prevention and Treatment of New World Screwworm Infestations in Cattle September 30, 2025
Brand New Tropical Medicine Curriculum Unveiled
Found under the ‘Resources’ tab of our website, the course was developed by Parasites Without Borders in conjunction with a team of fellows and medical educators at Columbia University Irving Medical Center and was revised by a panel of expert clinicians and researchers from all around the world.
Brand New Tropical Medicine Curriculum Unveiled Read More »
September 25, 2025
Clesrovimab for Prevention of RSV Disease in Healthy Infants | Mexico Boosts Controls on Cattle after New Screwworm Case Found Near U.S. Border in Nuevo Leon | More Measles Cases Now in 2025 Than Any Year Since It Was Declared Eliminated in 2000
September 25, 2025 Read More »
